 REHOVOT, Israel , Sept. 19, 2022 PRNewswire -- CollPlant NASDAQ: CLGN, a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products for tissue regeneration and organ manufacturing, today announced the Company will make a presentation on Recombinant Human Collagen-based Bioinks for Biofabrication and Modeling Applications at the International Conference on Biofabrication on September 28 th. 